Bioventus (BVS) Cash from Operations (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bioventus | 535.01 Mn | 544.52 Mn | 90.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -76.47% |
| Dec 31, 2025 | 26.15% |
| Sep 27, 2025 | 16.04% |
| Jun 28, 2025 | 234.18% |
| Mar 29, 2025 | -200.05% |
| Dec 31, 2024 | 87.30% |
| Sep 28, 2024 | -31.96% |
| Jun 29, 2024 | 352.49% |
| Mar 30, 2024 | -157.89% |
| Dec 31, 2023 | 268.79% |
| Sep 30, 2023 | -156.93% |
| Jul 1, 2023 | 333.53% |
| Apr 1, 2023 | -61.78% |
| Dec 31, 2022 | 4,023.42% |
| Oct 1, 2022 | -94.62% |
| Jul 2, 2022 | 113.98% |
| Apr 2, 2022 | -260.24% |
| Dec 31, 2021 | 23.90% |
| Oct 2, 2021 | -38.91% |
| Jul 3, 2021 | 196.05% |
| Apr 3, 2021 | -172.03% |
| Dec 31, 2020 | 17.92% |
| Sep 26, 2020 | 171.62% |
| Jun 27, 2020 | -55.80% |